Medical technologies and therapeutic interventions that help healthcare professionals in the fields of GI, Urology, Respiratory, Endotherapy and ENT deliver diagnostic, therapeutic and minimally invasive surgical procedures to improve clinical outcomes, reduce overall costs and enhance patient safety and quality of life.
Touchdown Ventures helps manage Olympus Innovation Ventures with a dedicated corporate venture capital team, partnering on all aspects of operating the fund. Touchdown employs 50+ investment professionals and operates CVC funds for more than 15 corporations.
- We invest in emerging medical device, diagnostic, and digital healthcare startups with solutions for specialists, surgeons, and patients.
- We strive to be a good partner. Our program is designed to support entrepreneurs through clinical validation, regulatory approval, and commercial distribution in global markets.
- We target financial and strategic return by investing in companies that can leverage our scale, resources, relationships, technical capabilities, and clinical expertise.
Stage-agnostic, with an emphasis on early to growth-stage startups
Priority Clinical Areas
Global, with a focus on North America, Europe, Israel, and Asia